InSitu Biologics
James Knapp was previously a financial planner at Ameriprise Financial Services, Inc. from April 2003 to April 2012. James is currently the Chairman at InSitu Biologics.
James Knapp has a Bachelor's degree in Business Management from Luther College, an Accredited Portfolio Management Advisor certification from the College for Financial Planning, and a Financial Planning Certificate from Minnesota State University, Mankato.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
InSitu Biologics
InSitu Biologics is an emerging biotech company focused on the development of a multi-phase prolonged-release drug delivery platform for localized treatment of pain, cancer, and infection.